Kruse Larsen

The foundation for success starts with solid political insight and experience. Kruse Larsen offers their clients Norway’s strongest team of advisors within public affairs, strategic communications, and crisis management. Kruse Larsen has battle-tested experience in handling business-critical political processes and media situations, anticipating challenges foreign companies may face in Norway. It is this competence and expertise Kruse Larsen offers their clients. Regardless of their needs, Kruse Larsen comprises proud professionals who always go the extra mile to help strategically, tactically, and operationally to champion clients’ business goals.


Merck is a leading science and technology company with specialists in Healthcare, Life Science and Electronics. Globally, more than 60,000 employees work to make a difference in people’s lives; from advancing gene editing technologies and discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices.

Merck was founded in 1668. The family remains the majority owner of the publicly listed company. Merck holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the business sectors of Merck operate as EMD Serono in healthcare, MilliporeSigma in life science, and EMD Performance Materials.


Takeda is a patient-focused, values-based, R&D-driven global biopharmaceutical company committed to bringing Better Health and a Brighter Future to people worldwide. Takeda’s passion and pursuit of potentially life-changing treatments for patients are deeply rooted in the company’s distinguished history in Japan since 1781. Takeda has a presence in approximately 80 countries, delivering highly innovative medicines and transformative care for patients around the world. In Norway, Takeda is based in Asker with around 245 employees.

Amazon Web Services

For over 15 years, Amazon Web Services has been the world’s most comprehensive and broadly adopted cloud offering. AWS has continually expanded its services to support virtually any cloud workload and now has more than 200 fully featured services for storage, databases, networking, analytics, machine learning and artificial intelligence (AI), Internet of Things (IoT), mobile, security, hybrid, virtual and augmented reality (VR and AR), media, and application development, deployment, and management from 84 Availability Zones within 26 geographic regions, with announced plans for 24 more Availability Zones and eight more AWS Regions in Australia, Canada, India, Israel, New Zealand, Spain, Switzerland, and the UAE. Millions of customers—including the fastest-growing startups, largest enterprises, and leading government agencies—trust AWS to power their infrastructure, become more agile, and lower costs.



Bayer is a Life Science company with a more than 150-year history and core competencies in the areas of health care and agriculture. With its focus on preventing, alleviating, and treating diseases and providing a reliable supply of high-quality food, feed, and plant-based raw materials, Bayer’s innovative products are contributing to finding solutions to some of the major challenges of our time – reflecting the company’s purpose, science for a better life. Bayer Norway is headquartered in Oslo and employs 155 people. Bayer’s vision is: Health for all, Hunger for none.


Sanofi has been leading pharmaceutical innovations for over 100 years. Globally, the company has more than 100,000 employees in over 100 countries and is headquartered in Paris, France. Sanofi is organized into three global business units, which all are represented in Norway: General Medicines, Specialty Care, and Vaccines. Sanofi-Aventis’ Norway branch is in Lysaker and employs 77 people.


AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialization of prescription medicines, primarily for the treatment of diseases in four therapy areas – Oncology, Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.


Thommessen is one of Norway’s leading commercial law firms, with offices in Oslo, Bergen, Stavanger, and London. Since the firm’s founding in 1856, Thommessen has been closely involved in most of the defining developments in Norwegian business. The company’s clients are Norwegian and international businesses, in both the private and public sector. Thommessen enables clients to achieve their objectives by understanding their challenges and opportunities.

Thommessen offers clients clear, well-founded, and practically oriented advice premised on an in-depth understanding of the factors affecting their interests, whether commercial, technological, societal, political, or global.

Boehringer Ingelheim

Boehringer Ingelheim develops breakthrough therapies that improve the lives of humans and animals. As a research-driven biopharmaceutical leader, the company creates value through innovation in areas of high unmet medical need. Founded in 1885 and family-owned ever since, Boehringer Ingelheim takes a long-term perspective. Around 50,000 employees serve more than 130 markets in the three business areas: Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing. In Norway, Boehringer Ingelheim employs 64 people. In 2021, Boehringer Ingelheim’s Norwegian Branch achieved a total net sales revenue of NOK 483,9 million.

EY Norge

EY is one of the largest professional services networks in the world and employs 312,000 globally. The company provides services that build trust and confidence in capital markets and economies around the world. EY develops outstanding leaders who deliver on the company’s promises to all of its stakeholders; building a better working world for the company’s people, clients, and communities. In Norway, EY was established in 1996 and employs 2,000 people across the country.